metricas

Annals of Hepatology

Suggestions
Annals of Hepatology Ahead of print
Journal Information

Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Comment on “Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma”
Zhiwei Wang, Lujie Xiang, Lingli Ye, Qingjing Ru
10.1016/j.aohep.2026.102182
Full text access
Pre-proof. Available online 15 January 2026
Name MASLD/MASH — and act on it
Jeffrey V. Lazarus, Mário G. Pessoa, Debbie L. Shawcross, Peter Schwarz, Grace L. Su, Simon Barquera
10.1016/j.aohep.2025.102171
Full text access
Available online 13 January 2026
De novo malignancies after liver transplantation: a 30-year multicenter Brazilian cohort
Larissa Machado e Silva Gomide, Julio Cezar Uili Coelho, Alexandre Coutinho Teixeira de Freitas, André Watanabe
10.1016/j.aohep.2026.102181
Full text access
Pre-proof. Available online 12 January 2026
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease
Yasser Fouad, Reda Elwakil, Faisal M. Sanai, Olusegun Ojo, Sameer Al Awadhi, Ponsiano Ocama, Nadia AbdelAty, Said A. Al-Busafi, ... Mohammed Eslam
10.1016/j.aohep.2026.102180
Full text access
Pre-proof. Available online 12 January 2026
Is FIB-4 the right tool for screening for liver fibrosis?
Leen J.M. Heyens, Demi P.A.van Malde, Gediz Dogay Us, Francesco Innocenti, Mathieu Struyve, Christophe Van Steenkiste, Sven Francque, Geert Robaeys, ... the MASLD research group
10.1016/j.aohep.2025.102176
Full text access
Uncorrected Proof. Available online 5 January 2026
Telemedicine and hybrid engagement models facilitate hepatitis C cascade of care during periods of healthcare disruption
Sabrina Fan, Haris Imsirovic, Curtis Cooper
10.1016/j.aohep.2025.102178
Full text access
Uncorrected Proof. Available online 5 January 2026
A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma
Anabel Sanchez-Martin, Rocio I.R. Macias, Luis Muñoz-Bellvís, Luis M. Gonzalez, Alejandro Forner, Maria Reig, Jose J.G. Marin, Oscar Briz
10.1016/j.aohep.2025.102179
Full text access
Uncorrected Proof. Available online 2 January 2026
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma
Stephen Lam Chan, Richard S. Finn, Julien Edeline, Sadahisa Ogasawara, Jennifer J. Knox, Bruno Daniele, Baek-Yeol Ryoo, Philippe Merle, ... Ann-Lii Cheng
10.1016/j.aohep.2025.102169
Full text access
Uncorrected Proof. Available online 2 January 2026
Outcomes and risk of relapse after living donor and deceased donor liver transplantation for alcohol-associated liver disease
Chloe Huen-Wai Choy, Hills King-Hei Suen, Tiffany Cho-Lam Wong, Miu-Yee Chan, Kin-Pan Au, Jeff Wing-Chiu Dai, James Yan-Yue Fung, Tan-To Cheung, Albert Chi-Yan Chan
10.1016/j.aohep.2025.102177
Full text access
Uncorrected Proof. Available online 29 December 2025
Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study
Byungyoon Yun, Juyeon Oh, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon
10.1016/j.aohep.2025.102175
Full text access
Uncorrected Proof. Available online 29 December 2025